Organization
Dongkook Pharmaceutical
3 clinical trials
Clinical trial
Bioequivalence Study to Evaluate Pharmacokinetics and Safety of AmBisome and DKF-5122 in Indicated Patients and Healthy AdultsStatus: Completed, Estimated PCD: 2022-01-28
Clinical trial
A Multi-center, Randomized, Double-blinded, Double-dummy, Parallel Group, 48-week, Phase III Clinical Trial to Evaluate the Efficacy and Safety of DKF-313 in Patients With Benign Prostatic HyperplasiaStatus: Completed, Estimated PCD: 2023-06-12
Clinical trial
A Phase 3, Multi-center, Single-group, Open-label Study to Evaluate the Efficacy and Safety of DKF-MA102 in Patients With Prostate CancerStatus: Recruiting, Estimated PCD: 2025-05-20